FM04 is a potent P-glycoprotein (P-gp) inhibitor (EC50 = 83 nM) used to inhibit P-gp activity through dual mechanisms: (1) binding to Q1193 and interacting with functionally critical residues H1195 and T1226; or (2) binding to the functionally critical residue I1115, thereby disrupting the R262-Q1081-Q1118 interaction pocket and uncoupling the ICL2-NBD2 interaction.